This section of Viatris.com contains information that may not be suitable for use in all countries due to varied regulatory requirements, data protection requirements and practices or medical practices, and distinctions among product approval and commercial availability. The information contained in each news release or statement posted on this page is presented as of the date it was issued. The company undertakes no obligation to update the information for changes or subsequent events after the date it was originally issued.
- Oct 30, 2020Mylan and Pfizer Receive Clearance from the U.S. Federal Trade Commission for Proposed Combination of Mylan and UpjohnPfizer Announces Record Date for the Proposed Transaction
- Sep 15, 2020The Companies Have Also Received Approvals in Australia and New Zealand; Combination on Track to Close in Fourth Quarter 2020
- Jul 9, 2020Announcement follows Mylan shareholder approval of Mylan's combination with Pfizer's Upjohn
- Jun 30, 202099.6% of Shares Voted in Favor of the Transaction
- Jun 18, 2020